Canada markets open in 5 hours 42 minutes

Nykode Therapeutics AS (5VB.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
1.2320-0.0290 (-2.30%)
As of 08:25AM CEST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
10,603
12,902
7,168
33,963
215,000
-
Operating Expenses
Research Development
-
29,358
26,774
16,300
10,627
-
Selling General and Administrative
-
6,278
8,892
9,283
8,559
-
Total Operating Expenses
69,607
70,984
60,324
44,738
36,738
-
Operating Income or Loss
-59,004
-58,082
-53,156
-10,775
178,262
-
Interest Expense
229
224
241
130
46
-
Income Before Tax
-48,542
-44,086
-50,983
-11,118
180,905
-
Income Tax Expense
-8,805
-8,932
-8,240
-1,704
31,130
-
Income from Continuing Operations
-39,737
-35,154
-42,743
-9,414
149,774
-
Net Income
-39,737
-35,154
-42,743
-9,414
149,774
-
Net Income available to common shareholders
-39,737
-35,154
-42,743
-9,414
149,774
-
Basic EPS
-0.14
-
-0.15
-0.03
0.54
-0.05
Diluted EPS
-0.14
-
-0.15
-0.03
0.51
-0.05
Basic Average Shares
305,532
-
290,119
286,345
279,643
283,628
Diluted Average Shares
305,532
-
290,119
286,345
296,145
283,628